Literature DB >> 17483068

Successful treatment with imatinib combined with less intensive chemotherapy (vincristine and dexamethasone) as induction therapy in a very elderly patient with Philadelphia chromosome-positive acute lymphoblastic leukemia.

Kazuhiro Nishii, Miho Sakakura, Tetsuya Tsukada, Hyou Ryuu, Naoyuki Katayama.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17483068     DOI： 10.1532/IJH97.06216

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  8 in total

1.  Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).

Authors:  Barbara Wassmann; Heike Pfeifer; Nicola Goekbuget; Dietrich W Beelen; Joachim Beck; Matthias Stelljes; Martin Bornhäuser; Albrecht Reichle; Jolanta Perz; Rainer Haas; Arnold Ganser; Mathias Schmid; Lothar Kanz; Georg Lenz; Martin Kaufmann; Anja Binckebanck; Patrick Brück; Regina Reutzel; Harald Gschaidmeier; Stefan Schwartz; Dieter Hoelzer; Oliver G Ottmann
Journal:  Blood       Date:  2006-04-25       Impact factor: 22.113

2.  Combination of intensive chemotherapy and imatinib can rapidly induce high-quality complete remission for a majority of patients with newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia.

Authors:  Masayuki Towatari; Masamitsu Yanada; Noriko Usui; Jin Takeuchi; Isamu Sugiura; Makoto Takeuchi; Fumiharu Yagasaki; Yasukazu Kawai; Shuichi Miyawaki; Shigeki Ohtake; Itsuro Jinnai; Keitaro Matsuo; Tomoki Naoe; Ryuzo Ohno
Journal:  Blood       Date:  2004-08-17       Impact factor: 22.113

3.  High-dose imatinib mesylate combined with vincristine and dexamethasone (DIV regimen) as induction therapy in patients with resistant Philadelphia-positive acute lymphoblastic leukemia and lymphoid blast crisis of chronic myeloid leukemia.

Authors:  D Rea; L Legros; E Raffoux; X Thomas; P Turlure; S Maury; B Dupriez; A Pigneux; B Choufi; O Reman; D Stéphane; B Royer; M Vigier; M Ojeda-Uribe; C Recher; H Dombret; F Huguet; P Rousselot
Journal:  Leukemia       Date:  2006-03       Impact factor: 11.528

4.  High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group.

Authors:  Masamitsu Yanada; Jin Takeuchi; Isamu Sugiura; Hideki Akiyama; Noriko Usui; Fumiharu Yagasaki; Tohru Kobayashi; Yasunori Ueda; Makoto Takeuchi; Shuichi Miyawaki; Atsuo Maruta; Nobuhiko Emi; Yasushi Miyazaki; Shigeki Ohtake; Itsuro Jinnai; Keitaro Matsuo; Tomoki Naoe; Ryuzo Ohno
Journal:  J Clin Oncol       Date:  2005-12-12       Impact factor: 44.544

5.  Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia--results of the prospective multicenter LALA-94 trial.

Authors:  Hervé Dombret; Jean Gabert; Jean-Michel Boiron; Françoise Rigal-Huguet; Didier Blaise; Xavier Thomas; André Delannoy; Agnès Buzyn; Chrystèle Bilhou-Nabera; Jean-Michel Cayuela; Pierre Fenaux; Jean-Henri Bourhis; Nathalie Fegueux; Christiane Charrin; Claude Boucheix; Véronique Lhéritier; Hélène Espérou; Elizabeth MacIntyre; Jean-Paul Vernant; Denis Fière
Journal:  Blood       Date:  2002-10-01       Impact factor: 22.113

6.  Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate.

Authors:  Deborah A Thomas; Stefan Faderl; Jorge Cortes; Susan O'Brien; Francis J Giles; Steven M Kornblau; Guillermo Garcia-Manero; Michael J Keating; Michael Andreeff; Sima Jeha; Miloslav Beran; Srdan Verstovsek; Sherry Pierce; Laurie Letvak; August Salvado; Richard Champlin; Moshe Talpaz; Hagop Kantarjian
Journal:  Blood       Date:  2003-10-09       Impact factor: 22.113

Review 7.  Twenty years' experience in allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in the Nagoya Blood and Marrow Transplantation Group.

Authors:  Hiroatsu Iida; Hiroshi Sao; Kenjiro Kitaori; Seiichi Gotoh; Makoto Yazaki; Seiji Kojima; Atsushi Wakita; Yasuo Morishima; Yoshihisa Kodera; Yoshihisa Morishita
Journal:  Int J Hematol       Date:  2004-01       Impact factor: 2.490

Review 8.  Bone marrow transplant in Ph+ ALL patients.

Authors:  I Avivi; A H Goldstone
Journal:  Bone Marrow Transplant       Date:  2003-04       Impact factor: 5.483
  8 in total
  1 in total

1.  Philadelphia chromosome-positive acute lymphoblastic leukemia with extramedullary and meningeal relapse after allogeneic hematopoietic stem cell transplantation that was successfully treated with dasatinib.

Authors:  Toshinori Kondo; Taizo Tasaka; Kana Matsumoto; Rui Matsumoto; Lisa Koresawa; Fuminori Sano; Hirotoshi Tokunaga; Yoshiko Matsuhashi; Hidekazu Nakanishi; Kunihiko Morita; Hideho Wada; Takashi Sugihara
Journal:  Springerplus       Date:  2014-04-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.